Giacomo Group has been acquired by FIDIM S.r.l.
The private shareholders of Giacomo Group have sold a stake in the company to FIDIM S.r.l.
Giacomo Group manages a network of four high-end restaurants, two bakeries, a deli shop, an R&D lab and a gastronomic management hub. With Milan at the core of its activities for over 60 years, the Group launched a restaurant in Tuscany in 2018. What made Giacomo stay ahead in dining trends was their uncompromising attitude to food selection, constantly updating menu offerings and an exquisite client service. The Group’s customer base includes international celebrities, top global politicians and Milan jetsetters. Its B2B business stream supplies food to Milan’s high-end horeca players. The company employs 150 people.
FIDIM is the investment vehicle of the Rovati family. In 1961, the Rovatis founded Rottapharm, an Italian pharma empire known for its cutting-edge research and massive acquisitions. The company was sold for US$2.5 billion to the Swedish group Meda in 2014. Currently, FIDIM has interests in biotech, real estate and private equity.
The new ownership structure and the new capital will allow the Group to consolidate its position among the leaders in the sector and expand into flagship locations.
Oaklins’ team in Italy served as the exclusive financial advisor to the seller in this transaction.
Marco Monti
CEO and Shareholder, Giacomo Group
Talk to the deal team
Related deals
OBI Group has acquired the OBI and individual DIG stores from Migros
As part of a strategic review, Migros has decided to divest its DIY business, which included several “Do It + Garden” and “OBI” locations. Migros had operated the Swiss OBI stores as a franchisee. In OBI Group Holding, Migros has found the ideal partner to ensure continuity for both its customers and employees.
Learn moreDen Berk Délice accelerates growth through strategic partnership
Den Berk Délice, a leading Belgian grower of specialty tomatoes, has entered a strategic partnership with Egeria, an independent investment firm, to realize its next growth phase.
Learn moreXiel Limited has been acquired by MIS Healthcare
MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.
Learn more